Abstract:Pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are ligand-activated transcription factors that regulate the expression of drug metabolizing enzymes and drug transporters. Since their discoveries, they have been studied as important factors for regulating processes related to drug efficacy, drug toxicity, and drug-drug interactions. However, their vast ligand-binding profiles extend into additional spaces, such as endogenously produced chemicals, microbiome metabolites, dietary compounds, and environmental pollutants. Therefore, PXR and CAR can respond to an enormous abundance of stimuli, resulting in significant shifts in metabolic programs and physiologic homeostasis. Naturally, PXR and CAR have been implicated in various diseases related to homeostatic perturbations, such as inflammatory bowel disorders, diabetes, and certain cancers. Recent findings have injected the field with new signaling mechanisms and tools to dissect the complex PXR and CAR biology and have strengthened the potential for future PXR and CAR modulators in the clinic. Here, we describe the historical and ongoing importance of PXR and CAR in drug metabolism pathways and how this history has evolved into new mechanisms that regulate and are regulated by these xenobiotic receptors, with a specific focus on small molecule ligands. To effectively convey the impact of newly emerging research, we have arranged five diverse and representative key recent advances, four specific challenges, and four perspectives on future directions. SIGNIFICANCE STATEMENT PXR and CAR are key transcription factors that regulate homeostatic detoxification of the liver and intestines. Diverse chemicals bind to these nuclear receptors, triggering their transcriptional tuning of the cellular metabolic response. This minireview revisits the importance of PXR and CAR in pharmaceutical drug responses and highlights recent results with implications beyond drug metabolism.

Advances in the Research of Pregnane X Receptor and Constitutive Androstane Receptor

Nuclear Receptors PXR and CAR: Implications for Drug Metabolism Regulation, Pharmacogenomics and Beyond

Advances in Search for Pregnane X Receptor

The Emerging Role of Constitutive Androstane Receptor and Its Cross Talk with Liver X Receptors and Peroxisome Proliferator-Activated Receptor A in Lipid Metabolism.

Roles of xenobiotic receptors in vascular pathophysiology.

Regulation of Pxr and Car by Protein-Protein Interaction and Signaling Crosstalk

Regulation of Nuclear Receptors PXR and CAR by Small Molecules and Signal Crosstalk: Roles in Drug Metabolism and Beyond

Function of pregnane X receptor in drug mechanism and research progress

Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes

Progresses of researches on the correlation between pregnane X receptor and CYP3A

Advance in the research on several nuclear receptors related to bile acid metabolism

Xenobiotic Receptors Car and Pxr

The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.

A Novel Pregnane X Receptor-Mediated and Sterol Regulatory Element-Binding Protein-Independent Lipogenic Pathway

Nuclear Hormone Receptors PXR and CAR and Metabolic Diseases

The role of pregnane X receptor (PXR) in substance metabolism

Regulation of Drug-Metabolizing Enzymes by Xenobiotic Receptors: PXR and CAR

Advances in regulation of pregnane X receptor-mediated drug transporter

The transcriptional regulation of drug enzymes and transporters mediated by Pregnane X receptor and its significant role in multidrug resistance

Signaling Control of the Constitutive Androstane Receptor （CAR）

Genistein,coumestrol and quercetin activate pregnane X receptor-mediated transcription of CYP3A4